Rashtriya Chemicals and Fertilizers Limited Board Approves Q3 Financial Results and Declares Interim Dividend

The Board of Directors of RCF met on February 12, 2026, to approve the Un-audited Financial Results for the quarter ended December 31, 2025 (Q3 FY26). Additionally, the Board declared an Interim Dividend of ₹1/- per equity share (10%). The dividend payment is scheduled by March 13, 2026, with a Record Date set for February 20, 2026.

Board Meeting Outcomes for Q3 FY26

Rashtriya Chemicals and Fertilizers Limited (RCF) announced the outcome of its Board Meeting held on Thursday, February 12, 2026. The Board officially considered and approved the key financial outcomes for the third quarter of the financial year.

Unaudited Financial Performance

The Board approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter ending December 31, 2025. These results were duly reviewed by the Audit Committee and accompanied by the Limited Review Report issued by the Statutory Auditors.

Declaration of Interim Dividend

A major highlight of the meeting was the declaration of an Interim Dividend for the Financial Year 2025-26. The Board has sanctioned a dividend of Rs. 1/- per equity share based on the face value of Rs. 10/-, equating to a (10%) payout.

The payment of this dividend will be made exclusively through the electronic mode on or before March 13, 2026.

Key Dates for Dividend Disbursement

To determine shareholder eligibility for this dividend, the Board has fixed the Record Date as Friday, February 20, 2026.

Compliance Disclosures

The company also provided mandatory disclosures, confirming that there was no outstanding default in the payment of loans or debt securities as of the quarter ending December 31, 2025. Furthermore, statements regarding the use of proceeds from listed debt instruments indicated no deviation or variation for the same period. Other regulatory disclosures pertaining to public issues or security cover were marked as Not Applicable.

The Board Meeting commenced at 12:15 pm and concluded at 3:15 pm on the date of the announcement.

Source: BSE

Previous Article

Natco Pharma Limited Announces 3rd Interim Dividend of Rs.1.50 for FY 2025-26

Next Article

Marksans Pharma Ltd. Q3 FY26 Earnings Call Highlights Steady Growth and Margin Expansion